Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D06BDB
|
||||
Former ID |
DNC008963
|
||||
Drug Name |
Isosorbide-2-benzylcarbamate-5-acetate
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [1] | ||
Structure |
![]() |
Download2D MOL |
|||
Formula |
C16H19NO6
|
||||
Canonical SMILES |
CC(=O)OC1COC2C1OCC2OC(=O)NCC3=CC=CC=C3
|
||||
InChI |
1S/C16H19NO6/c1-10(18)22-12-8-20-15-13(9-21-14(12)15)23-16(19)17-7-11-5-3-2-4-6-11/h2-6,12-15H,7-9H2,1H3,(H,17,19)/t12-,13+,14-,15-/m1/s1
|
||||
InChIKey |
RMUIRACCZOGQBC-LXTVHRRPSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Cholinesterase | Target Info | Inhibitor | [1] | |
PANTHER Pathway | Muscarinic acetylcholine receptor 1 and 3 signaling pathway | ||||
Muscarinic acetylcholine receptor 2 and 4 signaling pathway | |||||
Nicotinic acetylcholine receptor signaling pathway | |||||
WikiPathways | Irinotecan Pathway | ||||
References | |||||
REF 1 | J Med Chem. 2008 Oct 23;51(20):6400-9. Epub 2008 Sep 26.Isosorbide-2-carbamate esters: potent and selective butyrylcholinesterase inhibitors. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.